微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.04% | -97.88% | -20% | 96/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.05% | 113.89% | -97.52% | 93/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 2.02% | -57.38% | -24.34% | 78/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.67% | -34.07% | 41.27% | 74/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 1.89% | -25.59% | 625% | 70/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -0.36% | -132.14% | -107.59% | 110/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 4.74% | -40.15% | 17.04% | 64/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.05% | -24.86% | 59.45% | 69/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.54% | -42.53% | 126.79% | 69/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.12% | -38.12% | -85.86% | 73/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.92% | -5.6% | 46.94% | 51/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 5.39% | 2% | 21.95% | 60/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 4.42% | 16.62% | 144.2% | 53/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.81% | 2% | -78.43% | 65/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 8.39% | -25.75% | 121.37% | 73/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-06-30 | 3.79% | -13.86% | -66.46% | 80/141 | 9.74% | 九安医疗 | 140.94% | 行业排名> |
| 2021-12-31 | 11.3% | -11.37% | 156.82% | 74/141 | 18.45% | 九安医疗 | 142.25% | 行业排名> |
| 2021-06-30 | 4.4% | 27.54% | -65.49% | 86/141 | 11.59% | 九安医疗 | 142.71% | 行业排名> |
| 2020-12-31 | 12.75% | -44.57% | 269.57% | 76/141 | 26.27% | 热景生物 | 121.78% | 行业排名> |
| 2020-06-30 | 3.45% | 2% | -85% | 83/141 | 15.17% | 热景生物 | 99.69% | 行业排名> |
| 2019-12-31 | 23% | 2% | 2% | 27/141 | 14.66% | 热景生物 | 99.09% | 行业排名> |